Communicable Disease Reporting

How to Report

NBS Users: Report conditions via Morbidity Report in NBS

Non-NBS Users: Report via the specific reporting form below:

• STIs and HIV/AIDS
• Tuberculosis (cases & suspects)
• Latent TB infection
• Animal bites
• Confidential Report for Communicable Diseases -- use for all other reportable conditions

  *If you are having trouble accessing the above State Form, please try again without using a VPN, check your downloads folder, and/or use Google Chrome

• Acquired Immunodeficiency Syndrome (AIDS)
• Acute Flaccid Myelitis (AFM)
• Anaplasmosis
• Animal bite or exposure
• Arboviral disease or infection, domestic
  • California serogroup viruses
  • Eastern equine encephalitis virus
  • Heartland virus
  • Jamestown Canyon virus
  • La Crosse virus
  • Powassan virus
  • St. Louis encephalitis virus
  • West Nile virus
  • Western equine encephalitis virus
• Arboviral disease or infection, imported
  • Chikungunya virus
  • Dengue virus
  • Japanese encephalitis
  • Oropouche virus
  • Yellow fever
  • Zika virus
• Babesiosis
• Brucellosis
• Campylobacteriosis
• Candida auris
• Carbapenemase-Producing Organisms (CPO)
• Chancroid
• Chlamydia trachomatis, genital infection
  • Lymphogranuloma venereum
• Coccidioidomycosis
• COVID-19-associated deaths (all ages)
• Cronobacter infection, invasive, infants (younger than 1 year of age)
• Cryptosporidiosis
• Cyclosporiasis
• Ehrlichiosis
• Escherichia coli (E. coli) infection (Shiga toxin-producing E. coli (STEC)) including, but not limited to, E. coli O157 and other serogroups)
• Giardiasis
• Gonorrhea
  • Disseminated gonococcal infection
• Haemophilus influenzae, invasive disease, (including antimicrobial susceptibility testing)
• Hansen’s disease (leprosy)
• Hantavirus pulmonary syndrome and non-pulmonary syndrome
• Hemolytic uremic syndrome (HUS), post-diarrheal
• Hepatitis, viral, Type A
• Hepatitis, viral, Type B (acute and chronic)
• Hepatitis, viral, Type B, pregnant woman or perinatally exposed infant
• Hepatitis, viral, Type C (acute and chronic)
• Hepatitis, viral, Type C, pregnant woman or perinatally exposed infant
• Hepatitis, viral, Type Delta
• Hepatitis, viral, Type E
• Hepatitis, viral, unspecified
• Histoplasmosis
• HIV infection*
• HIV infection, pregnant  woman or perinatally exposed infant*
• Influenza-associated death (all ages)
• Latent tuberculosis infection (LTBI)
• Legionellosis
• Leptospirosis
• Listeriosis
• Lyme disease
• Malaria
• Mpox (formerly known as Monkeypox)
• Multisystem Inflammatory Syndrome in adults (MIS-A)
• Multisystem Inflammatory Syndrome in children (MIS-C)
• Mumps
• Pandrug-resistant Organisms
• Pertussis (whooping cough)
• Psittacosis
• Q Fever
• Rabies, postexposure prophylaxis administration
• Salmonellosis, non-typhoidal
• Shigellosis
• Spotted fever rickettsiosis, including Rocky Mountain Spotted fever
• Streptococcus pneumoniae, invasive disease (including antimicrobial susceptibility testing)
• Streptococcus, Group A, invasive disease
• Syphilis
• Syphilis, congenital (pregnant woman and/or infant)
• Tetanus
• Toxic shock syndrome (streptococcal  or staphylococcal)
• Trichinellosis
• Tuberculosis disease, reportable upon suspicion
• Typhoid and paratyphoid fever, cases and carriers
• Vancomycin-resistant Staphylococcus aureus (VRSA) and Vancomycin-intermediate Staphylococcus aureus (VISA)
• Varicella (chickenpox)
• Vibriosis (non-cholera Vibrio infection)
• Yersiniosis, non-pestis

* Pursuant to 410 IAC 1-2.5, HIV infection and related laboratory results must be reported directly to the Indiana Department of Health

How to Report

Report via electronic laboratory reporting.

For facilities unable to submit via ELR, please fax reports to 317-234-2812.

• Anaplasma phagocytophilium
• Arboviruses including, but not limited to:
  • California serogroup viruses
  • Chikungunya virus
  • Dengue virus
  • Heartland virus
  • Jamestown Canyon virus
  • Japanese encephalitis virus
  • La Crosse virus
  • Oropouche virus
  • Powassan virus
  • St.Louis encephalitis virus
  • Western equine encephalitis virus
  • West Nile virus
  • Yellow fever virus
  • Zika virus
• Babesia spp.
• Bordetella pertussis
• Borrelia burgdorferi
• Brucella spp.
• Campylobacter spp.
• Candida auris
• Carbapenemase-producing Enterobacterales, Pseudomonas aeruginosa, and Acinetobacter baumannii*
• Chlamydia psittaci
• Chlamydia trachomatis
  • Lymphogranuloma venereum (LGV) (C. trachomatis serotypes L1, L2, or L3)
• Clostridium tetani
• Coccidioides spp.
• Coxiella burnetii
• Cronobacter spp., infants (younger than 1 year of age)
• Cryptosporidium spp.
• Cyclospora cayetanensis
• Ehrlichia spp.
• Escherichia coli (E. coli) infection (Shiga toxin-producing (STEC), including, but not limited to, E. coli O157, E. coli O157:H7, non-O157 E. coli, and Shiga toxin detected)
• Giardia spp.
• Grimontia hollisae (Vibrio hollisae)
• Haemophilus ducreyi
• Haemophilus influenzae, invasive disease*
• Hantavirus, including Sin Nombre virus, Seoul virus, and other hantaviruses
• Hepatitis, viral, Type A, Anti-HAV IgM or RNA detected
• Hepatitis, viral, Type B^†
• Hepatitis, viral, Type C^†
• Hepatitis, viral, Type Delta^†
• Hepatitis, viral, Type E, Anti-HEC IgM and IgG
• Hepatitis, viral, unspecified
• Histoplasma capsulatum
• HIV and related retroviruses^†
• Influenza viruses
• Interferon gamma release assay (IGRA) for tuberculosis (positive results only)
• Legionella spp.
• Leptospira spp.
• Mpox (Monkeypox) virus, including Non-variola Orthopox virus and Orthopox virus
• Mumps virus
• Mycobacterium leprae
• Mycobacterium tuberculosis complex
• Neisseria gonorrhoeae (list anatomic site to determine if disseminated infection)*
• Pandrug-resistant Organisms*
• Photobacterium damselae (Vibrio damsela)
• Plasmodium spp.
• Pneumocystis carinii (Pneumocystis pneumonia)
• Rickettsia (non-rickettsii spp.)
• Rickettsia rickettsii
• Salmonella spp. (non-typhoidal)*
• Salmonella serotype Paratyphi (Paratyphoid fever)*
• Salmonella serotype Typhi (Typhoid fever)*
• SARS-CoV-2**
• Shigella spp.*
• Streptococcus, group A (Streptococcus pyogenes), invasive disease*
• Streptococcus pneumoniae, invasive disease*
• Treponema pallidum
• Trichinella spiralis
• Vancomycin-resistant Staphylococcus aureus (VRSA) and Vancomycin-intermediate Staphylococcus aureus (VISA)*
• Varicella-zoster virus
• Vibrio spp.
• Yersinia spp., Enterocolitica, Pseudotuberculosis

^* Include antimicrobial susceptibility testing
^** Only laboratories and testing sites that submit results via electronic lab reporting (ELR)
^† Further guidance on the second page of the Indiana Reportable Result/Pathogen List for Laboratories